4530 — Hisamitsu Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual cashflow statement for Hisamitsu Pharmaceutical Co, fiscal year end - February 29th, JPY millions except per share, conversion factor applied.

	2020 February 29th	2021 February 28th	2022 February 28th	2023 February 28th	2024 February 29th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	26,155	12,197	12,956	16,113	19,186
Depreciation
Amortisation
Non-Cash Items	-1,688	-1,746	-2,814	-3,803	-4,114
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-1,324	-9,242	4,736	-4,534	-2,057
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	27,394	5,288	19,199	12,728	18,187
Capital Expenditures	-3,726	-3,388	-4,193	-7,908	-13,036
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-13,503	11,203	-8,867	-15,960	10,524
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-17,229	7,815	-13,060	-23,868	-2,512
Financing Cash Flow Items	-153	-210	-190	-203	-247
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-11,726	-7,187	-15,189	-14,687	-16,691
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-1,786	4,357	-5,106	-20,822	941